A Case Series: Effect of Comorbidities on the Outcomes of Prolotherapy Injection for Frozen Shoulder Patients

Nuralam Sam, Irawan Yusuf, Irfan Idris, Endy Adnan, Ratna Darjanti Haryadi, Firdaus Hamid, Muhammad Andry Usman, Muhammad Phetrus Johan, Andi Alfian Zainuddin, Nuralam Sam, Irawan Yusuf, Irfan Idris, Endy Adnan, Ratna Darjanti Haryadi, Firdaus Hamid, Muhammad Andry Usman, Muhammad Phetrus Johan, Andi Alfian Zainuddin

Abstract

Frozen shoulder (FS) is a disease caused by an inflammatory condition that causes severe pain and decreased range of motion by loss of glenohumeral mobility. Frozen Shoulder restricts daily life's functional aspect, increasing morbidity. Hypertension and diabetes mellitus are risk factors that make an FS poor prognosis during treatment because of the diabetes glycation process and hypertension-enhanced vascularization. Prolotherapy injects an irritant solution into the tendon, joints, ligaments, and joint spaces to release growth factors and collagen deposition, reducing pain, restoring joint stability, and increasing the quality of life. We report 3 cases of patients with confirmed FS. Patient A with no comorbidity, patient B with diabetes mellitus, and patient C with hypertension, with all patient's chief complaints of shoulder pain and limited ROM, and symptoms affected the general quality of daily life. This patient was provided injection with Prolotherapy treatment combined with physical therapy intervention. Patient A had significantly improved ROM to maximum after 6 weeks with relieved pain and improved shoulder function. Patients B and C showed increased ROM, still tiny, decreased pain, and improved shoulder function. In conclusion, prolotherapy demonstrated a beneficial effect in a patient with FS with comorbidities, although not to the maximum extent in patients without comorbidity.

Keywords: comorbidity; frozen shoulder; protherapy; quality of life; range of motion.

Conflict of interest statement

The authors declare no conflicts of interest for this work.

© 2023 Sam et al.

References

    1. Ryu K, Dongchan K, Lim G, Kim E, Lee SH. Ultrasound-guided prolotherapy with polydeoxyribonucleotide for painful rotator cuff tendinopathy. Pain Res Manag. 2018;2018:5. doi:10.1155/2018/8286190
    1. Challoumas D, Biddle M, McLean M, Millar NL. Comparison of treatments for frozen shoulder: a systematic review and meta-analysis. JAMA Netw Open. 2020;3(12):e2029581. doi:10.1001/jamanetworkopen.2020.29581
    1. Lho YM, Ha E, Cho CH, et al. Inflammatory cytokines are overexpressed in the subacromial bursa of frozen shoulder. J Shoulder Elbow Surg. 2013;22(5):666–672. doi:10.1016/j.jse.2012.06.014
    1. Akbar M, McLean M, Garcia-Melchor E, et al. Fibroblast activation and inflammation in frozen shoulder. PLoS One. 2019;14(4):e0215301. doi:10.1371/journal.pone.0215301
    1. Linsell L, Dawson J, Zondervan K, et al. Prevalence and incidence of adults consulting for shoulder conditions in UK primary care; patterns of diagnosis and referral. Rheumatology. 2006;45(2):215–221. doi:10.1093/rheumatology/kei139
    1. Dupeyron A, Gelis A, Sablayrolles P, Bousquet PJ, Julia M, Herisson C. Heterogeneous assessment of shoulder disorders: validation of the standardized index of shoulder function. J Rehabil Med. 2010;42(10):967–972. doi:10.2340/16501977-0627
    1. Fernandes MR. Correlation between functional disability and quality of life in patients with adhesive capsulitis. Acta Ortop Bras. 2015;23(2):81–84. doi:10.1590/1413-78522015230200791
    1. Lee HV, Lee SJ, Nazarian A, Rodriguez EK. Adhesive capsulitis of the shoulder: review of pathophysiology and current clinical treatments. Shoulder Elbow. 2016;9(2):75–84. doi:10.1177/1758573216676786
    1. Cohen C, Ejnisman B. Epidemiology of frozen shoulder. In: Shoulder Stiffness. Heidelberg: Springer Berlin; 2015:21–30.
    1. Itoi E, Arce G, Bain GI, et al. Shoulder stiffness: current concepts and concerns. Arthroscopy. 2016;32:1402–1414. doi:10.1016/j.arthro.2016.03.024
    1. Wong CK, Levine WN, Deo K, et al. Natural history of frozen shoulder: fact or fiction? A systematic review. Physiotherapy. 2017;103:40–47. doi:10.1016/j.physio.2016.05.009
    1. Cucchi D, Marmotti A, De Giorgi S, et al. Risk factors for shoulder stiffness: current concepts. Joints. 2017;5(04):217–223. doi:10.1055/s-0037-1608951
    1. Sözen T, Başaran NÇ, Tınazlı M, et al. Musculoskeletal problems in diabetes mellitus. Eur J Rheumatol. 2018;5(4):258–265. doi:10.5152/eurjrheum.2018.18044
    1. Dyer BP, RathodMistry T, Burton C, et al. Diabetes as a risk factor for the onset of frozen shoulder: a systematic review and meta-analysis. BMJ Open. 2023;13:e062377. doi:10.1136/bmjopen-2022-062377
    1. Kim Y-S, Kim J-M, Lee Y-G, Hong O-K, Kwon H-S, Ji J-H. Intercellular Adhesion Molecule-1 (ICAM-1, CD54) is increased in adhesive capsulitis. J Bone Joint Surg Am. 2013;95(4):e18–1–8. doi:10.2106/jbjs.k.00525
    1. Hauser RA, Lackner JB, Steilen-Matias D, Harris DK. A systematic review of dextrose prolotherapy for chronic musculoskeletal pain. Clin Med Insights Arthritis Musculoskelet Disord. 2016;9:139–159. PMID: 27429562; PMCID: PMC4938120. doi:10.4137/CMAMD.S39160
    1. Goswami A. Prolotherapy. J Pain Palliat Care Pharmacother. 2012;26(4):376–378. PMID: 23216178. doi:10.3109/15360288.2012.734900
    1. DeChellis DM, Cortazzo MH. Regenerative medicine in the field of pain medicine: prolotherapy, platelet-rich plasma therapy, and stem cell therapy-theory and evidence. Tech Reg Anesth Pain Manag. 2011;15(2):74–80. doi:10.1053/j.trap.2011.05.002
    1. Ramirez J. Adhesive capsulitis: diagnosis and management. Am Fam Physician. 2019;99(5):297–300. PMID: 30811157.
    1. Hanchard N, Goodchild L, Thompson J, et al. Evidence-based clinical guidelines for the diagnosis, assessment and physiotherapy management of contracted (frozen) shoulder: a quick reference summary. Physiotherapy. 2012;98:117–120. doi:10.1016/j.physio.2012.01.001
    1. Pandey V, Madi S. Clinical guidelines in the management of frozen shoulder: an update! JOIO. 2021;55:299–309. doi:10.1007/s43465-021-00351-3
    1. Dyer BP, Burton C, Rathod-Mistry T, et al. Diabetes as a prognostic factor in frozen shoulder: a systematic review. Arch Rehabil Res Clin Transl. 2021;3(3):100141. ISSN 2590-1095. doi:10.1016/j.arrct.2021.100141
    1. Selley RS, Johnson DJ, Nicolay RW, et al. Risk factors for adhesive capsulitis requiring shoulder arthroscopy: a clinical retrospective case series study. J Orthop. 2020;19:14–16. doi:10.1016/j.jor.2019.11.024
    1. Cao W, Chen J, Pu J, Fan Y, Cao Y. Risk factors for the onset of frozen shoulder in middle-aged and elderly subjects within 1 year of discharge from a hospitalization that involved intravenous infusion: a prospective cohort study. Front Med. 2022;9:911532. PMID: 35795630; PMCID: PMC9251169. doi:10.3389/fmed.2022.911532
    1. Sarasua SM, Floyd S, Bridges WC, et al. The epidemiology and etiology of adhesive capsulitis in the US medicare population. BMC Musculoskelet Disord. 2021;22(1). doi:10.1186/s12891-021-04704-9
    1. Seven MM, Ersen O, Akpancar S, et al. Effectiveness of prolotherapy in the treatment of chronic rotator cuff lesions. Orthop Traumatol Surg Res. 2017;103(3):427–433. doi:10.1016/j.otsr.2017.01.003
    1. Jensen K, Rabago D, Best TM, et al. Early inflammatory response of knee ligaments to prolotherapy in a rat model. J Orthop Res. 2008;26(6):816–823. doi:10.1002/jor.20600
    1. Jensen KT, Rabago D, Best TM, et al. Longer term response of knee ligaments to prolotherapy in a rat injury model. Am J Sports Med. 2008;36(7):1347–1357. doi:10.1177/0363546508314431

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe